186 related articles for article (PubMed ID: 22905853)
1. The role of initial success rates and other factors in determining reliability of outcomes of phosphodiesterase inhibitor therapy for erectile dysfunction: a pooled analysis of 17 placebo-controlled trials of tadalafil for use as needed.
Sontag A; Rosen RC; Litman HJ; Ni X; Araujo AB
J Sex Med; 2013 Feb; 10(2):541-50. PubMed ID: 22905853
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR
J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781
[TBL] [Abstract][Full Text] [Related]
3. Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success.
Shabsigh R; Donatucci C; Costabile R; Perelman MA; Burns P; Zeigler H; Wong DG
Int J Impot Res; 2010; 22(1):1-8. PubMed ID: 19657349
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials.
Rosen RC; Shabsigh R; Kuritzky L; Wang WC; Sides GD
Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.
Seftel AD; Wilson SK; Knapp PM; Shin J; Wang WC; Ahuja S
J Urol; 2004 Aug; 172(2):652-7. PubMed ID: 15247754
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM
J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
[TBL] [Abstract][Full Text] [Related]
8. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
Porst H; Gacci M; Büttner H; Henneges C; Boess F
Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses.
Rubio-Aurioles E; Casabé A; Torres LO; Quinzaños L; Glina S; Filimon I; Kopernicky V; Leñero E
J Sex Med; 2008 Aug; 5(8):1965-76. PubMed ID: 18466266
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis examining first-dose success, success by dose, and maintenance of success among men taking tadalafil for erectile dysfunction.
Schulman CC; Shen W; Stothard DR; Schmitt H
Urology; 2004 Oct; 64(4):783-8. PubMed ID: 15491720
[TBL] [Abstract][Full Text] [Related]
11. Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study.
Rosen RC; Padma-Nathan H; Shabsigh R; Saikali K; Watkins V; Pullman W
J Sex Med; 2004 Sep; 1(2):193-200. PubMed ID: 16422974
[TBL] [Abstract][Full Text] [Related]
12. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
[TBL] [Abstract][Full Text] [Related]
13. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials.
Shabsigh R; Burnett AL; Eardley I; Sharlip ID; Ellsworth PI; Garcia CS; Natanegara F; Ahuja S
BJU Int; 2005 Oct; 96(6):857-63. PubMed ID: 16153217
[TBL] [Abstract][Full Text] [Related]
14. Effects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo-controlled studies.
Paduch DA; Bolyakov A; Polzer PK; Watts SD
BJU Int; 2013 Feb; 111(2):334-43. PubMed ID: 23356749
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study.
Chen KK; Jiann BP; Lin JS; Lee SS; Huang ST; Wang CJ; Ju-Ton H; Su CK; Costigan TM; Emmick JT
J Sex Med; 2004 Sep; 1(2):201-8. PubMed ID: 16422975
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
[TBL] [Abstract][Full Text] [Related]
17. Impact of tadalafil once daily in men with erectile dysfunction--including a report of the partners' evaluation.
Althof SE; Rubio-Aurioles E; Kingsberg S; Zeigler H; Wong DG; Burns P
Urology; 2010 Jun; 75(6):1358-63. PubMed ID: 20206967
[TBL] [Abstract][Full Text] [Related]
18. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
Young JM; Feldman RA; Auerbach SM; Kaufman JM; Garcia CS; Shen W; Murphy AM; Beasley CM; Hague JA; Ahuja S
J Androl; 2005; 26(3):310-8. PubMed ID: 15866997
[TBL] [Abstract][Full Text] [Related]
19. Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
Shabsigh R; Kim ED; Rosen RC; Shinghal R; Natanegara F; Muram D; Wong DG
Int J Impot Res; 2008; 20(6):554-60. PubMed ID: 18997808
[TBL] [Abstract][Full Text] [Related]
20. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
